Envoy Medical, Inc. (NASDAQ:COCH) Short Interest Down 34.7% in December

Envoy Medical, Inc. (NASDAQ:COCH) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 158,800 shares, a decrease of 34.7% from the December 15th total of 243,100 shares. Based on an average trading volume of 239,400 shares, the days-to-cover ratio is presently 0.7 days. Approximately 1.8% of the shares of the stock are sold short.

Envoy Medical Price Performance

NASDAQ COCH opened at $1.40 on Wednesday. The stock has a 50-day moving average of $1.89 and a 200-day moving average of $2.42. Envoy Medical has a 1-year low of $1.08 and a 1-year high of $11.46.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Ascendiant Capital Markets lifted their price target on Envoy Medical from $8.75 to $9.00 and gave the company a “buy” rating in a research report on Friday, December 6th. Brookline Capital Management initiated coverage on shares of Envoy Medical in a research report on Monday, October 14th. They set a “buy” rating and a $9.00 price objective on the stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.